Arti Kanjolia

Scientist Ii @Scribe Therapeutics

San Francisco, CA, US
EMAILS
a••••••••@scribetx.com
MOBILE NUMBERS
+14•••••••20

Signup · Get unlimited contacts

WORK HISTORY

May 2024 — Present

Scientist Ii @Scribe Therapeutics

View department →

CA, US

Screening Platform Development

EDUCATION

2011 — 2013

Northeastern University

Master of Science - MS, Biotechnology

2006 — 2010

Manipal Institute of Technology

Bachelor of Engineering, Biotechnology

SKILLS

Protein ChemistryRt-PcrElisaConfocal MicroscopyImmunohistochemistryQpcrTissue CultureRecombinant Dna TechnologyProtein ExpressionLife SciencesMolecular CloningBiochemistryPcrRna IsolationFormulationImmunologyAssay DevelopmentWestern BlottingGlpsHplcDna ExtractionTransfectionNanodropDnaAffinity ChromatographyMolecular BiologyBiotechnologyProtein PurificationImmunofluorescenceScreeningFlow CytometryDna SequencingGel ElectrophoresisSpectrophotometryLaboratoryBacterial TransformationProteomicsCancerSds-PageImmunoassays

ABOUT ARTI KANJOLIA

An accomplished scientist with over 12 years of expertise in cell biology, drug discovery, in-vitro pharmacology, gene editing, and next-generation sequencing (NGS). Highly skilled in in vivo and ex vivo applications of genome editing tools with an in-depth comprehension of the CRISPR/Cas9 platform and delivery optimization, RNA biology, high throughput screening, on and off-target assessments for preclinical research and regulatory filings. Experienced in creating and leading very collaborative teams in fast-moving matrixed companies with mentorship and empathy. Deeply passionate about solving technical problems and drug delivery challenges with creativity and translating impactful research to enable the creation of curative treatments for patients.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Arti Kanjolia — Email, Phone Number & Contact Info | Unifers